Step by Stepa HemeOncBuddy patient portal

Mirvetuximab soravtansine

Illustration: Mirvetuximab soravtansine

Say it: mir-veh-TUX-ih-mab sor-av-TAN-seen · Brand names: Elahere

Mirvetuximab soravtansine is a targeted medicine that delivers a strong cancer drug straight to cancer cells that have a protein called folate receptor alpha.

What it is

It is made of two parts joined together: an antibody that finds a protein called folate receptor alpha on cancer cells, and a strong cancer medicine. The antibody carries the medicine straight to the cancer cell, so more of it reaches the cancer and less reaches healthy cells. A test on your tumor shows if you can get this medicine.

Often used for

How you get it

You get it as an infusion into a vein at a clinic. It is usually given once every 3 weeks, and you get medicines before each infusion to help prevent reactions and nausea. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Mirvetuximab soravtansine?
Mirvetuximab soravtansine is a targeted medicine that delivers a strong cancer drug straight to cancer cells that have a protein called folate receptor alpha. Brand names: Elahere.
What is Mirvetuximab soravtansine used for?
ovarian cancer; fallopian tube cancer; primary peritoneal cancer (cancer of the lining of the belly).
How is Mirvetuximab soravtansine given?
You get it as an infusion into a vein at a clinic. It is usually given once every 3 weeks, and you get medicines before each infusion to help prevent reactions and nausea. Your schedule may be different.
What are the common side effects of Mirvetuximab soravtansine?
Blurry vision or other vision changes. Dry eyes or eye discomfort. Feeling tired. Nausea. Belly pain. Diarrhea or constipation. Numbness or tingling in your hands or feet.
When should I call my care team while taking Mirvetuximab soravtansine?
Any new or worse vision problems, eye pain, or sensitivity to light; New or worse cough, shortness of breath, or chest pain; A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher; Very bad belly pain, swelling, or vomiting; Trouble breathing, chills, flushing, or rash during or after the infusion.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.